205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.31%
Revenue growth 1.25-1.5x ON's 1.59%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
3.64%
Gross profit growth under 50% of ON's 87.85%. Michael Burry would be concerned about a severe competitive disadvantage.
12.92%
EBIT growth below 50% of ON's 138.01%. Michael Burry would suspect deeper competitive or cost structure issues.
10.33%
Operating income growth under 50% of ON's 133.71%. Michael Burry would be concerned about deeper cost or sales issues.
34.92%
Net income growth under 50% of ON's 135.03%. Michael Burry would suspect the firm is falling well behind a key competitor.
33.33%
EPS growth under 50% of ON's 135.65%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
33.33%
Diluted EPS growth under 50% of ON's 135.65%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-29.56%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-27.87%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
41.96%
Dividend growth of 41.96% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-48.82%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-112.03%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
3.06%
10Y revenue/share CAGR under 50% of ON's 71.75%. Michael Burry would suspect a lasting competitive disadvantage.
-24.01%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-27.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-52.04%
Negative 5Y OCF/share CAGR while ON is at 17.99%. Joel Greenblatt would question the firm’s operational model or cost structure.
385.77%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
143.28%
Net income/share CAGR at 50-75% of ON's 245.86%. Martin Whitman might question if the firm’s product or cost base lags behind.
73.69%
Below 50% of ON's 12132.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
48.33%
Positive short-term CAGR while ON is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
145.52%
5Y equity/share CAGR is in line with ON's 142.72%. Walter Schloss would see parallel mid-term profitability and retention policies.
49.68%
3Y equity/share CAGR similar to ON's 54.30%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
83.48%
Dividend/share CAGR of 83.48% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
77.18%
Dividend/share CAGR of 77.18% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-2.22%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
7.14%
AR growth well above ON's 12.36%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.72%
Inventory growth well above ON's 0.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.20%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
45.27%
BV/share growth above 1.5x ON's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-3.48%
We’re deleveraging while ON stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
10.68%
We increase R&D while ON cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.52%
We cut SG&A while ON invests at 1.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.